Connecting omics signatures of diseases, drugs, and mechanisms of actions with iLINCS
Marcin Pilarczyk(University of Miami), Mario Medvedovic(University of Cincinnati), Stephan C. Schürer(University of Miami), Michal Kouril(University of Cincinnati), D. Vidović(University of Miami), Amar Koleti(University of Miami), Avi Ma’ayan(Icahn School of Medicine at Mount Sinai), Nicholas A. Clark(Harvard University), Juozas Vasiliauskas(Veterans Health Administration), Vasileios Stathias(University of Miami), Rashid Karim(University of Cincinnati), Daniel Clarke(Icahn School of Medicine at Mount Sinai), Mark F. Bennett(The University of Melbourne), John F. Reichard(University of Cincinnati), Jacek Biesiada(University of Cincinnati), Behrouz Shamsaei(Microsoft (United States)), Shana White(University of Cincinnati), Jarek Meller(Cincinnati Children's Hospital Medical Center), Lixia Zhang(Handan College), Yan Ren(Henan Agricultural University), Huan Xu(The Coordinating Center), Sarah E. Davidson(University of Cincinnati), Kurt E. Roberts(Trinity Health), Wen Niu(Jiangsu University), Naim Al Mahi(University of Cincinnati)
Cited by 47
Related Papers
Single-cell immune landscape of human atherosclerotic plaques
|Nature Medicine|2019|967
Proteogenomic and metabolomic characterization of human glioblastoma
|Cancer Cell|2021|692